Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2017-10-09

M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.

Volmar CH, Salah-Uddin H, Janczura KJ, Halley P, Lambert G, Wodrich A, Manoah S, Patel NH, Sartor GC, Mehta N, Miles NTH, Desse S, Dorcius D, Cameron MD, Brothers SP, Wahlestedt C.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.1707544114

Bibliografisk träff 2017-03-01

Histone deacetylase inhibitor M344 significantly improves nuclear reprogramming, blastocyst quality, and in vitro developmental capacity of cloned pig embryos.

Jin L, Guo Q, Zhu HY, Xing XX, Zhang GL, Xuan MF, Luo QR, Luo ZB, Wang JX, Choe HM, Paek HJ, Yin XJ, Kang JD.

J Anim Sci · journal article · DOI 10.2527/jas.2016.1240

Bibliografisk träff 2013-04-01

Retraction notice to "M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells" [Gynecol. Oncol. 101 (2006) 108-113].

Författaruppgift saknas

Gynecol Oncol · retraction notice · DOI 10.1016/j.ygyno.2012.09.022

Bibliografisk träff 2011-08-27

HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.

Yeung A, Bhargava RK, Ahn R, Bahna S, Kang NH, Lacoul A, Niles LP.

Biomed Pharmacother · research support, non-u.s. gov't; journal article · DOI 10.1016/j.biopha.2011.06.007

Bibliografisk träff 2011-08-19

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells.

Weberpals JI, O'Brien AM, Niknejad N, Garbuio KD, Clark-Knowles KV, Dimitroulakos J.

Cancer Cell Int · research-article; journal article · DOI 10.1186/1475-2867-11-29

Bibliografisk träff 2010-09-09

Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination.

St Germain C, O'Brien A, Dimitroulakos J.

Cancer Cell Int · research-article; journal article · DOI 10.1186/1475-2867-10-32

Bibliografisk träff 2009-06-01

Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.

Li X, Chen BD.

Am J Biomed Sci · research-article; journal article · DOI 10.5099/aj090400352

Bibliografisk träff 2006-06-14

Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases.

Hölsken A, Eyüpoglu IY, Lueders M, Tränkle C, Dieckmann D, Buslei R, Hahnen E, Blümcke I, Siebzehnrübl FA.

Acta Neuropathol · journal article · DOI 10.1007/s00401-006-0082-8

Bibliografisk träff 2006-05-25

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.

Riessland M, Brichta L, Hahnen E, Wirth B.

Hum Genet · research support, non-u.s. gov't; journal article · DOI 10.1007/s00439-006-0186-1

Tillbakadragen publikation 2005-11-02

M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Narahara H.

Gynecol Oncol · retracted publication; research support, non-u.s. gov't; journal article · DOI 10.1016/j.ygyno.2005.09.044

Bibliografisk träff 2002-02-01

Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.

Remiszewski SW, Sambucetti LC, Atadja P, Bair KW, Cornell WD, Green MA, Howell KL, Jung M, Kwon P, Trogani N, Walker H.

J Med Chem · journal article · DOI 10.1021/jm015568c

Bibliografisk träff 1999-11-01

Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

Jung M, Brosch G, Kölle D, Scherf H, Gerhäuser C, Loidl P.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm991091h